Bioorganic & Medicinal Chemistry

Papers
(The TQCC of Bioorganic & Medicinal Chemistry is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Synthesis and antiproliferative activity of (−)-cleistenolide, (6S)-cleistenolide and 4-substituted cleistenolide analogues132
Current Japanese pharmaceutical chemistry90
Targeting prolidase. A survey of the literature data to depict a structure-activity relationship frame and to address future studies for drug development73
Innovative synthesis and purification method of fluorescent and bifunctional substrates for self-labelling protein tags72
Site-specific construction of triptolide-based antibody-drug conjugates47
Sustainable electrochemical C(sp3) − H oxygenation using water as the oxygen source46
Antimycobacterial and anti-inflammatory activities of thiourea derivatives focusing on treatment approaches for severe pulmonary tuberculosis43
Exploring novel A2AAR antagonists: Design, synthesis, and evaluation of 2,6,9-trisubstituted purine derivatives as promising antifibrotic agents42
Production and synthesis of a novel 191Pt-labeled platinum complex and evaluation of its biodistribution in healthy mice40
Editorial Board40
Synthesis and medicinal chemistry of tetronamides: Promising agrochemicals and antitumoral compounds38
Development of delivery carriers for plasmid DNA by conjugation of a helical template to oligoarginine38
Synthesis and biological evaluation of pyrazole-fused oleanolic acid derivatives as novel inhibitors of inflammatory and osteoclast differentiation36
Graphical abstract TOC35
RNA-templated chemical synthesis of proapoptotic L- and d-peptides35
Design, synthesis and validation of a new Crimped Head-Piece for DNA-Encoded libraries generation34
Contents continued34
Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors32
A DNA-encoded library special issue32
Design, synthesis, biological activity and molecular docking studies of triazolopyridine derivatives as ASK1 inhibitors31
Discovery of trisubstituted meta-carboranes as T cell activators by regulating CD28 cytoplasmic region and SH2 domains of Grb2 and PI3K interactions31
Decades old glitazones still find niche in drug discoveries as PPAR-γ agonists: medicinal chemistry perspective, structure-activity relationships and therapeutic implications30
Multiple approaches to repurposing drugs for neuroblastoma30
Janus dendritic ionizable lipids with fine designed headgroup and tails to improve mRNA delivery efficiency29
Research progress of STAT3-based dual inhibitors for cancer therapy28
Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling28
Discovery of novel 2,8-diazaspiro[4.5]decan-1-one derivatives as potent RIPK1 kinase inhibitors28
Sulfadoxine derivatization through multicomponent reactions to obtain new antiplasmodial compounds28
Discovery of 3-hydroxymethyl-azetidine derivatives as potent polymerase theta inhibitors27
Design, synthesis and antibacterial evaluation of oxazolidinone derivatives containing N-methylglycyl or quaternary ammonium salts27
Diterpenoids from the whole plants of Croton yunnanensis and their bioactivities27
Design, synthesis and evaluation the bioactivities of novel 1,3-dimethyl-6-amino-1H-indazole derivatives as anticancer agents26
Targeting m6A binding protein YTHDFs for cancer therapy26
Combining CuAAC reaction enables sialylated Bi- and triantennary pseudo mannose N-glycans for investigating Siglec-7 interactions25
Peptide-based CE-SELEX enables convenient isolation of aptamers specifically recognizing CD20-expressing cells25
Synthesis, evaluation of anti-breast cancer activity in vitro of ICS II derivatives and summary of the structure-activity relationship25
Current development and structure–activity relationship study of berberine derivatives25
Pentacyclic triterpene-amino acid derivatives induced apoptosis and autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway24
More than forty years of nucleic acid structural science23
Graphical abstract TOC23
Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum23
Design and evaluation of novel analogs of 2-amino-4-boronobutanoic acid (ABBA) as inhibitors of human gamma-glutamyl transpeptidase23
Graphical abstract TOC23
Corrigendum to “Discovery of 1,3,4-oxadiazole derivatives as potential antitumor agents inhibiting the programmed cell death-1/programmed cell death-ligand 1 interaction” [Bioorg. Med. Chem. 46 (2021)22
Editorial Board22
Contents continued21
Graphical abstract TOC21
Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD)21
Assessing the rigidity of cubanes and bicyclo(1.1.1)pentanes as benzene bioisosteres21
Oligonucleotides containing 2′-O-methyl-5-(1-phenyl-1,2,3-triazol-4-yl)uridines demonstrate increased affinity for RNA and induce exon-skipping in vitro21
Graphical abstract TOC21
Editorial Board21
Structure activity relationship and target prediction for ABX464 analogues in Caenorhabditis elegans20
CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles20
Graphical Abstract Contents Continued20
Design, synthesis and biological evaluation of novel indole derivatives as gut-selective NaPi2b inhibitors20
Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease20
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors20
1,3-Disubstituted-1,2,4-triazin-6-ones with potent activity against androgen receptor-dependent prostate cancer cells20
Chemical similarities and differences among inhibitors of nitric oxide synthase, arginase and dimethylarginine dimethylaminohydrolase-1: Implications for the design of novel enzyme inhibitors modulati20
Concise synthesis of piperarborenine B20
A pharmacophore-based approach to demonstrating the scope of alcohol dehydrogenases20
Graphical abstract TOC20
Discovery of tetracyclic 1,2,4-triazoline-fused dibenzo[b,f][1,4]oxazepine as a potent anti-colorectal cancer agent with good efficacy and low toxicity20
A TNF-α blocking peptide that reduces NF-κB and MAPK activity for attenuating inflammation19
Synthesis and biological evaluation of O4′-benzyl-hispidol derivatives and analogs as dual monoamine oxidase-B inhibitors and anti-neuroinflammatory agents19
Design, Synthesis, and biological evaluation of 7H-Pyrrolo[2,3-d]pyrimidines as potent HPK1 kinase inhibitors19
Design, synthesis and biological evaluation of arylpropylamine derivatives as potential multi-target antidepressants19
Development of novel quinoline-NO donor hybrids inducing human breast cancer cells apoptosis via inhibition of topoisomerase I19
Design, synthesis and biological evaluation of EGFR kinase inhibitors that spans the orthosteric and allosteric sites19
Cytotoxicity of cinchona alkaloid organocatalysts against MES-SA and MES-SA/Dx5 multidrug-resistant uterine sarcoma cell lines19
Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents19
Graphical abstract TOC18
Di-indenopyridines as topoisomerase II-selective anticancer agents: Design, synthesis, and structure–activity relationships17
Editorial Board17
Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [18F]GSK148216017
3-Amino-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carbonitrile: A fluorescent molecule that induces differentiation in PC12 cells17
Small phenolic inhibitors of PfATP6, a Plasmodium falciparum calcium ATPase, as prototype antimalarials17
Synthesis and mammalian cell compatibility of light-released glycan precursors for controlled metabolic engineering17
Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors17
Design, synthesis and biological evaluation of phosphoroxy quinazoline derivatives as potential EGFRT790M/C797S inhibitors17
Graphical abstract TOC17
4-Arylidene curcumin derivatives in vitro inhibit α-Synuclein aggregation and disaggregate the preformed fibril17
Editorial Board17
The 2022 Monkeypox outbreak: How the medicinal chemistry could help us?17
In Vivo Imaging of Tumor Hypoxia by Maintaining Green Fluorescence of 9-Aminoanthracene Under Hypoxic Conditions17
The design of protozoan phosphoribosyltransferase inhibitors containing non-charged phosphate mimic residues17
Design and synthesis 1H-Pyrrolo[2,3-b]pyridine derivatives as FLT3 inhibitors for the treatment of Acute myeloid Leukemia17
Directly arylated oligonucleotides as fluorescent molecular rotors for probing DNA single-nucleotide polymorphisms17
In vivo imaging of fluorescent albumin modified with pyruvylated-human-type complex oligosaccharide reveals sialylation-like biodistribution and kinetics16
Introduction of a carboxylic acid group into pyrazolylpyridine derivatives increased selectivity for inhibition of the 20-HETE synthase CYP4A11/4F216
A turn for the worse: Aβ β-hairpins in Alzheimer’s disease16
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display16
Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist16
Two distinct rotations of bithiazole DNA intercalation revealed by direct comparison of crystal structures of Co(III)•bleomycin A2 and B2 bound to duplex 5′-TAGTT sites16
Ligand- and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia16
Inhibition of cytochrome bd oxidase in Mycobacterium tuberculosis by benzothiazole amides16
Structural optimization of naturally derived Ar-turmerone, as novel neuroinflammation suppressors effective in an Alzheimer mouse model16
Design and identification of brain-penetrant, potent, and selective 1,3-oxazole-based cholesterol 24-hydroxylase (CH24H) inhibitors16
Dihydroartemisinin improves hypercholesterolemia in ovariectomized mice via enhancing vectorial transport of cholesterol and bile acids from blood to bile16
Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction16
Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of using a S···O binding interaction for 16
Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer15
Graphical abstract TOC15
Thiazolidinones and related analogues as efficient antitrypanosomal agents15
Identification of novel influenza polymerase PB2 inhibitors using virtual screening approach and molecular dynamics simulation analysis of active compounds15
(±)-Agrimonolide: Efficient synthesis and treatment of inflammatory bowel disease via JAK1/STAT3 pathway inhibition15
Design and synthesis of phenanthridinone and phenanthridine derivatives and their radiosensitizing activity15
Synthesis and biological evaluation of indoline derivatives as CDGSH iron sulfur domain 2 activators15
Editorial Board15
Graphical abstract TOC15
ClpP-based MtPTAC technology enables targeted degradation of inner mitochondrial membrane proteins15
Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon15
Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA14
Discovery of structurally diverse diazatricyclododecenes as lysosomotropic autophagy inhibitors14
Synthesis, biological activity and mechanism of action of novel allosecurinine derivatives as potential antitumor agents14
Modulation of aryl hydrocarbon receptor activity by halogenated indoles14
C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transporters14
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy14
Dimeric 1-(1H-indol-3-yl) urea as potent STING inhibitor to alleviate cisplatin-induced acute kidney injury in mice14
Discovery of a potent C20-oxime pachysandra alkaloid analogue promising for treatment of hepatocellular carcinoma14
An insight into the mechanistic role of (-)-Ampelopsin F from Vatica chinensis L. in inducing insulin secretion in pancreatic beta cells14
Design, synthesis and molecular modelling studies of bile acid-curcumin conjugates as potential antiproliferative agents for breast cancer14
Influence of N-arylsulfonamido d-valine N-substituents on the selectivity and potency of matrix metalloproteinase inhibitors14
Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors14
Design, synthesis and in vitro validation of bivalent binders of SARS-CoV-2 spike protein: Obeticholic, betulinic and glycyrrhetinic acids as building blocks14
Scaffold hopping and sidechain modification from a flavone scaffold lead to discovery of potent, selective CK2A2 inhibitors with favorable properties for CNS activity14
Contents continued13
Discovery of polymethoxyphenyl-pyridines bearing amino side chains as tubulin colchicine-binding site inhibitors13
Graphical abstract TOC13
Phenotypic screen identifies FOXO inhibitor to counteract maturation and promote expansion of human iPS cell-derived cardiomyocytes13
Recent research progress of β-carbolines as privileged scaffold in the discovery of anticancer agent (2019–2024)13
Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease13
Truxillic acid monoamides as fatty acid binding protein 5 inhibitors13
Stereoisomers of cannabidiols and their pharmacological activities – A potentially novel direction for cannabinoids13
Synthetic studies on the extracellular domain of the T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) using Trt-K10 solubilizing tags13
Graphical Abstract TOC13
Chemical design of radioiodinated probes with a metabolizable linkage for target-selective imaging of systemic amyloidosis13
Editorial Board13
Graphical abstract TOC13
PET imaging of VEGFR and integrins in glioma tumor xenografts using 89Zr labelled heterodimeric peptide13
Rational design of AIEgens through π-bridge engineering for dual-modal photodynamic and photothermal therapy12
Corrigendum to “Discovery of novel Quinazoline-based KRAS G12C inhibitors as potential anticancer agents” [Bioorg. Med. Chem. 71 (2022) 116962]12
Synthesis and antibacterial properties under blue LED light of conjugates between the siderophore desferrioxamine B (DFOB) and an Iridium(III) complex12
Recent advances on synthesis and biological activities of C-17 aza-heterocycle derived steroids12
Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM study12
FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I12
From natural products to HDAC inhibitors: An overview of drug discovery and design strategy12
Synthesis and characterization of new acid-functionalized porphyrins displaying antimicrobial activity against gram positive bacteria, yeasts and filamentous fungi with or without ultra-high irradianc12
Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives12
Fluorescent probes and degraders of the sterol transport protein Aster-A12
Generation of an RNA aptamer against LipL32 of Leptospira isolated by Tripartite-hybrid SELEX coupled with in-house Python-aided unbiased data sorting12
Synthesis and biological evaluation of novel isobenzofuran-1(3H)-one derivatives as antidepressant agents12
Growth factors and their peptide mimetics for treatment of traumatic brain injury12
Editorial Board12
Editorial Board12
Editorial Board12
Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer12
Discovery and structure-activity relationship of Morita-Baylis-Hillman adducts as larvicides against dengue mosquito vector, Aedes aegypti (Diptera: Culicidae)12
Exploring novel pyrazole-nitroimidazole hybrids: Synthesis and antiprotozoal activity against the human pathogen trichomonas vaginalis12
Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice12
Discovery and optimization of anthraquinone derivatives containing substituted bisbenzyloxy groups as a novel scaffold damaged endoplasmic reticulum and against hepatocellular carcinoma cells12
Discovery and biological evaluation of novel dual PTP1B and ACP1 inhibitors for the treatment of insulin resistance11
Graphical abstract TOC11
Discovery of evodiamine derivatives as potent insecticide candidates11
Target discovery of bioactive natural products with native-compound-coupled CNBr-activated Sepharose 4B beads (NCCB): Applications, mechanisms and outlooks11
Graphical abstract TOC11
Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance11
Editorial Board11
An assessment of the mutational load caused by various reactions used in DNA encoded libraries11
Graphical abstract TOC11
Discovery and development of small-molecule heparanase inhibitors11
Graphical abstract TOC11
Editorial Board11
Structure-based design of a novel series of cholesterol 24-hydroxylase (CH24H) inhibitors bearing 1,3-oxazole as a heme–iron binding group11
Synthesis and biophysical properties of tetravalent PEG-conjugated antisense oligonucleotide11
The most common linkers in bioactive molecules and their bioisosteric replacement network11
Selenoneine-inspired selenohydantoins with glutathione peroxidase-like activity11
Biocompatible conjugated polymer nanoparticles labeled with 225Ac for tumor endoradiotherapy11
Dual-responsive drug release and fluorescence imaging based on disulfide-pillar[4]arene aggregate in cancer cells11
Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction11
Structure-based lead optimization to improve potency and selectivity of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid series of heparanase-1 inhibitor11
Effect of helicity and hydrophobicity on cell-penetrating ability of arginine-rich peptides10
Evaluation of potential anticonvulsant fluorinated N-benzamide enaminones as T-type Ca2+ channel blockers10
Elongation of N6-benzyladenosine scaffold via Pd-catalyzed C–C bond formation leads to derivatives with antiflaviviral activity10
Potential COX-2 inhibitors modulating NF-κB/MAPK signaling pathways: Design, synthesis and evaluation of anti-inflammatory activity of Pterostilbene-carboxylic acid derivatives with an oxime ether moi10
A special issue on artificial intelligence for drug discovery10
Structure-based screening combined with computational and biochemical analyses identified the inhibitor targeting the binding of DNA Ligase 1 to UHRF110
Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase10
Synthesis of 1,8-cineole derivatives and evaluation of their cytoprotective effects against cisplatin-induced HK-2 cell injury10
Synthesis and biological evaluation of 4H-benzo[e][1,3]oxazin-4-ones analogues of TGX-221 as inhibitors of PI3Kβ10
Natural scaffold, modern strategy: Coumarin hybrids as potential carbohydrate-digesting enzyme inhibitors-A decade of medicinal chemistry exploration (2015–2025)10
Design of a potent and selective dual JAK1/TYK2 inhibitor10
Discovery of acetohydroxyacid synthase inhibitors as anti-tuberculosis lead compounds from natural products10
Synthesis of 6-ethoxyphenyl 4-fluorobenzenesulfonate-tagged thiosemicarbazones as carbonic anhydrase inhibitors: In-vitro and in silico approach10
Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors10
Design, synthesis, and pharmacological evaluation of N-(3-carbamoyl-1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide derivatives as interleukin-1 receptor-associated kinase 4 inhibitors with reduced potenti10
Thiazolidinedione-based structure modification of ergosterol peroxide provides thiazolidinedione-conjugated derivatives as potent agents against breast cancer cells through a PI3K/AKT/mTOR pathway10
Inhibition of the hERG potassium ion channel by different non-nucleoside human cytomegalovirus polymerase antiviral inhibitor series and the exploration of variations on a pyrroloquinoline core to red10
Saturation transfer difference (STD)-NMR spectroscopy in drug discovery: A comprehensive review on identified potential hits based on natural and synthetic scaffolds against therapeutic drug targets10
Design, synthesis, and biological evaluation of 2-arylamino-4-(piperidin-4-yloxy)pyrimidines as potent EGFRT790M/L858R inhibitors to treat non-small cell lung cancer10
Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity9
Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies9
Synthesis of sp3-rich chiral bicyclo[3.3.1]nonanes for chemical space expansion and study of biological activities9
Recent applications of seven-membered rings in drug design9
Structure activity relationships leading to the identification of the indirect activator of AMPK, R4199
Graphical abstract TOC9
Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase IIα inhibitors for the therapy of small cell lung cancer9
Design, classification, and adverse effects of NSAIDs: A review on recent advancements9
Synthesis and evaluation of sulfonamide derivatives targeting EGFR790M/L858R mutations and ALK rearrangement as anticancer agents9
Editorial Board9
Editorial Board9
Design, synthesis, and bioactivity study on Lissodendrins B derivatives as PARP1 inhibitor9
A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing9
Editorial Board9
RAD18-catalysed formation of ubiquitination intermediate mimic of proliferating cell nuclear antigen PCNA9
Discovery of novel 3-butyl-6-benzyloxyphthalide Mannich base derivatives as multifunctional agents against Alzheimer's disease9
Identification of potent α-amylase inhibitors via dynamic combinatorial chemistry9
Suramin analogues protect cartilage against osteoarthritic breakdown by increasing levels of tissue inhibitor of metalloproteinases 3 (TIMP-3) in the tissue9
Advances in the development of Rho GTPase inhibitors9
Engineered B7-H3-targeted VHH-Fc fusion antibody demonstrates rapid tumor accumulation for infrared imaging in pancreatic cancer xenograft model9
Synthesis and biological evaluation of sulfonylpyridine derivatives as potential anti-chlamydia agents9
Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L9
Graphical Abstract TOC9
Synthesis and biological evaluation of hybrids from optically active ring-opened 3-N-butylphthalide derivatives and 4-fluro-edaravone as potential anti-acute ischemic stroke agents9
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense oligonucleotide delivery9
Virtual screening, synthesis, optimization and anti-inflammatory activity of novel chromones as specific COX-2 inhibitors9
Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential9
Corylin induces UGT1A1 via PPARs/AhR and exerts hepatoprotection in mice9
Design, synthesis, and biological evaluation of a potential long-acting glucagon-like peptide-1 (GLP-1) analog9
Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents9
Synthesis and biological evaluation of aminobenzamides containing purine moiety as class I histone deacetylases inhibitors9
Discovery of CN0 as a novel proteolysis-targeting chimera (PROTAC) degrader of PARP1 that can activate the cGAS/STING immunity pathway combined with daunorubicin9
Synthesis and antimicrobial studies of cadasides analogues via on-resin esterification9
Design, in silico study, and efficient synthesis of N-acylhydrazones in deep eutectic solvents: potential anticonvulsant agents9
Design, synthesis and anti-rheumatoid arthritis activity of target TLR4 inhibitors9
Glutathione-responsive PROTAC for targeted degradation of ERα in breast cancer cells9
Graphical abstract TOC9
New phenylpiperazine-thiazolidine-2,4-dione hybrids targeting MAO inhibition: Synthesis, biological evaluation, kinetic study and in silico insights9
Discovery of pyrido[4,3-d]pyrimidinone derivatives as novel Wee1 inhibitors9
Editorial Board9
Contents continued9
Graphical abstract TOC9
Tenuistones A–H, novel flavonoid derivatives from Miliusa tenuistipitata with anti-proliferative and anti-migration activities against triple-negative breast cancer cells9
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease9
Harnessing polyhydroxylated pyrrolidines as a stabilizer of acid alpha-glucosidase (GAA) to enhance the efficacy of enzyme replacement therapy in Pompe disease9
Drug discovery targeting protein arginine methyltransferase 5 (PRMT5): an update9
Revisiting recent unusual drug-DNA complex structures: Implications for cancer and neurological disease diagnostics and therapeutics8
Contents continued8
Recent achievements in molecular insights, anticancer activities, and comparative structure activity relationships of thiazolidin-4-one derivatives as EGFR inhibitors (2019-present)8
0.27617812156677